Skip to main content
SpringerLink
Log in

HIV HGP-30W vaccine (Cel-Sci)

  • Section 1: HIV Vaccine
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kahn JO, Stites DP, Scillian J, et al. Aphase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Res Hum Retroviruses 1992 Aug; 8: 1321–5

    PubMed  CAS  Google Scholar 

  2. Sarin PS, Talmadge JE, Heseltine P, et al. Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection againstHIV-1 virus challenge in SCID mice. Vaccine 1999 Jan; 17: 64–71

    Article  PubMed  CAS  Google Scholar 

  3. Cel-Sci Corporation. The politics of AIDS vaccines in the developing world [media release]. Vienna (VA): Cel-Sci Corporation, 1 Dec 1998

    Google Scholar 

  4. Cel-Sci Corporation. AIDS vaccine shows promising cellular immune responses [media release]. Vienna (VA): Cel-Sci Corporation, 15 Jan 1999

    Google Scholar 

  5. Naylor PH, Sztein MB, Wada S, et al. Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine: HGP-30-KLH. Int J Immunopharmacol 1991; 13 Suppl. 1: 117–27

    Article  PubMed  CAS  Google Scholar 

  6. Goldstein AL, Naylor PH, Sarin PS, et al. Progress in the development of a P-17 based HIV vaccine: safety and potential efficacy of the HGP-30 synthetic peptide vaccine in humans. AIDS Res Hum Retroviruses 1992 May; 8: 939

    Google Scholar 

  7. Goldstein AL, Sarin PS, Markham R, et al. Cytotoxic and humoral immune responses to HIV-1 P17 synthetic peptide HGP-30 in human volunteers. 9th International Conference on AIDS; 1993 Jun 7–11; Berlin, 492

    Google Scholar 

  8. Cel-Sci Corporation. Cel-Sci announces presentation of clinical details of AIDS study with HGP-30 vaccine at XI International Conference on AIDS [media release]. Vienna (VA): Cel-Sci Corporation, 12 Jul 1996

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HIV HGP-30W vaccine (Cel-Sci). Drugs in R&D 1, 453–455 (1999). https://doi.org/10.2165/00126839-199901060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901060-00007

Keywords

Search

Navigation